ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members. The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process. In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.

See more Open Access Option

Indexed in:

Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

1.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.254

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.414

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Continuing Education

Radium-223 in the treatment of bone metastases in patients with castration-resistant prostate cancer. Review and procedure

Radio-223 en el tratamiento de metástasis óseas en pacientes con cáncer de próstata resistente a la castración. Revisión de la literatura y procedimiento

J. Orcajo-Rincona, A.P. Caresia-Arózteguib,

Corresponding author

paulacaresia@gmail.com

Corresponding author.

, M. del Puig Cózar-Santiagoc, J.R. García-Garzónd, M. de Arcocha-Torrese, R.C. Delgado-Boltonf, M.J. García-Vellosog, S. Alvarez-Ruizh, A.M. García-Vicentei

a Servicio de Medicina Nuclear, Hospital General Universitario Gregorio Marañón, Madrid, Spain

b Servicio de Medicina Nuclear, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain

c Servicio de Medicina Nuclear, ERESA – Hospital General Universitario de Valencia, Valencia, Spain

d Unitat PET/TC CETIR-ERESA, Esplugues de Llobregat, Barcelona, Spain

e Unidad de Radiofarmacia, Hospital Universitario Marqués de Valdecilla, Santander, Spain

f Departamento de Diagnóstico por Imagen y Medicina Nuclear, Hospital San Pedro-Centro de Investigación Biomédica de La Rioja (CIBIR), Logroño, La Rioja, Spain

g Servicio de Medicina Nuclear, Clínica Universidad de Navarra, Pamplona, Spain

h Servicio de Medicina Nuclear, Hospital Universitario Miguel Servet, Zaragoza, Spain

i Servicio de Medicina Nuclear, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Read

Times
was read the article

Total PDF

Total HTML

Share statistics

Article information

ISSN: 22538089
Original language: English

DOI:10.1016/j.remnie.2018.03.001